Overview: founded in 2012, Nanjing Huanglong Biotechnology Co., Ltd. (hereinafter referred to as "Huanglong biotechnology") is a wholly-owned subsidiary of Xinjiang baihuacun Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Baihua pharmaceutical - 600721"). In the form of MAH, relying on the superior resources of listed companies, we are committed to the research and development, declaration, production, transfer and sales of small molecule chemicals.
Mission: take overseas drugs with expired patents in the field of special diseases and domestic generic drugs instead of imported drugs as the core of the project, gain insight into the market, make forward-looking layout, create diversified service platforms such as drug license and achievement transfer, and imitate progressiveness drugs with clinical value or not yet introduced in China to meet the drug needs of patients
Assets: the registered capital is 20 million yuan, the net value of fixed assets is 70.9731 million yuan, covering an area of 4379.31 square meters and a building area of 11337.21 square meters
Geographical location: the address is located in the core area of Xianlin University Town (No. 9 Weidi Road, Xianlin University Town, Xianlin street, Qixia District, Nanjing). The park is located in the University Science and Technology Industrial Park of Xianlin University Town, south of national highway 312, east of Jiuxiang River, east of Yuanhua Road, west of Xishan substation, south of Weidi road and north of Qimin West Road.